Home
About + Prices
Contact Us
News Team
Social Media
Distribution
References
Archive
Share this story:
Kazia Therapeutics talks positive pre-clinical data for EVT801
Contact Details
Proactive Investors
Jonathan Jackson
+61 413 713 744
Jonathan@proactiveinvestors.com